RxDoctor Payments Data

George Valentini, MD

Plastic and Reconstructive Surgery · Hopkinsville, KYNPI 1174704829

Payments from drug & device makers

What this record shows

This record is dominated by other: $13,687 of the $15,318 with a category attached, or 89.4%. Mentor Worldwide LLC accounts for 89.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $13,977 and has fallen 99.2% since, to $113 in 2025.

$15,318in general payments, 2019–2025

Across 90 payments — averaging $170.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$14K
  • Organogenesis Inc.$417
  • Smith+Nephew$367
  • Melinta Therapeutics, LLC$201
  • Kerecis Limited$185
  • AbbVie$167
  • plus $295 from 13 others

What the payments were for

  • Speaking & faculty fees$160%
  • Food & beverage$1,61511%
  • Other$13,68789%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,318 in reported general payments places this provider in the 85th percentile of 43 plastic and reconstructive surgery providers in Kentucky.

See all plastic and reconstructive surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$133,288
Medicare patients
182
Services billed
2,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin214$1,625
Gentamicin Sulfate27$832
Levofloxacin18$220
Doxycycline Hyclate16$186
Ciprofloxacin Hcl11$133
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$88

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →